Elsevier

1y

Safeguarding the vital work of researchers requires constant rigor and vigilance. As the world’s leading scientific publisher, Elsevier is investing heavily in human expertise and technology to identify fraudulent content and prevent it from entering the scientific record.

Elsevier

1y

Navigating the ever-growing and overwhelming volume of scientific literature just became easier. Introducing new ScienceDirect AI - a cutting-edge generative AI tool to help researchers instantly extract, summarize and compare trusted insights from millions of full-text articles and books on the world’s largest platform for peer-reviewed research. ✨ Broadest and deepest verified content set with power of generative AI – get mission-critical insights from the world’s largest body of quality peer-reviewed full-text research used by millions of researchers. 🔗 Traceable claims, rooted in the scientific record – reliable insights with clear links to precise sources of information to support integrity of research. ⚡ Built with and for researchers – Tested by 30,000+ researchers and librarians around the world, ScienceDirect AI helps reduce literature research time by up to 50%. ScienceDirect AI is built to give researchers more time to focus on shaping human progress. See how it works. 👇 https://www.linkedin.com/posts/elsevier_introducing-sciencedirect-ai-activity-7305483131761954817-YZF2?utm_source=share&utm_medium=member_desktop&rcm=ACoAABQkFNcBn2dYNwGDdbWHPA_rBVLYedfl_E0

Elsevier

1y

How can Germany maintain its scientific leadership in an evolving global research landscape? A new Elsevier report explores the strengths of Germany’s research ecosystem — and the challenges ahead. From academic excellence to deep industry collaboration, Germany stands out as a hub for scientific advancement. But gaps remain in turning research into application, especially in emerging tech like quantum and AI. Explore key insights: http://spkl.io/6048fFFvn

Elsevier

1y

ClinicalKey AI has won the 2025 MedTech Breakthrough Award for AI Innovation. ClinicalKey AI is recognized for its global expansion, added functionality in the clinical workflow, continuing education and board submission features, and expanded content coverage with practice guidelines from the American College of Cardiology. You can read more about the announcement here: http://spkl.io/6042f0LLk

Elsevier

1y

Using 🐍 antibodies from a hyper-immune human donor, scientists have developed an antivenom for the world's deadliest snakes. “The donor, for a period of nearly 18 years, had undertaken hundreds of bites and self-immunizations with escalating doses from 16 species of very lethal snakes that would normally a kill a horse,” first author Dr Jacob Glanville explained. Read more and check out the study: https://www.linkedin.com/pulse/antivenom-neutralizes-neurotoxins-19-deadliest-snakes-elsevier-m2eve/?trackingId=m%2FvT85LVTGeSc2FJjMO5Ig%3D%3D

Elsevier

1y

With Scopus AI, you can now take your research on the go! Scopus AI’s latest updates offer an optimized mobile experience, enabling you to navigate the full depth of Scopus knowledge anytime, anywhere. We’ve also introduced new features to optimize your research workflow, including the ability to revisit and build upon previous queries, ask follow-up questions, and easily identify emerging research trends - all supported by curated and comprehensive Scopus data. Learn more on: http://spkl.io/6045fLvml

Elsevier

1y

Elsevier has pushed roughly half a million ClinicalTrials.gov entries into Embase, its subscription biomedical database. The update lets R&D teams run a single search that pulls trial data from 200‑plus countries and matches it with Embase’s peer‑reviewed papers, in‑press manuscripts and conference abstracts. Elsevier notes that traditional approaches to synthesizing data from multiple sources is error prone and tedious. According to Mirit Eldor, Managing Director of Life Sciences at Elsevier, the move addresses a clear need. “Researchers are under increasing pressure to conduct comprehensive evidence searches with accuracy and efficiency, ensuring no critical information is overlooked,” Eldor stated in the announcement. “The incorporation of clinical trials data into Embase is the latest example of Elsevier’s commitment to developing innovative solutions that enhance researchers’ workflows.”

Elsevier

1y

This Nurses Week, we celebrate the incredible impact nurses have on transforming lives and shaping the future of healthcare. Your compassion, skill, and unwavering dedication make a difference every day. At Elsevier, we are proud to be your trusted partner on this journey—from education to practice—providing the resources and tools you need to empower your growth and enhance your impact. Join us in honoring your contributions and explore Elsevier’s nurse resource page for the latest insights and support as you continue to inspire meaningful change in every life you touch: http://spkl.io/6040f0ZZa

Elsevier

1y

Have you ever felt “lost” in a movie? 🧠 In a recent study published in the Cell Press journal Neuron, researchers have mapped out what happens in our brains when we’re absorbed in a film. By using fMRI scans, a team at Massachusetts Institute of Technology was able to track 24 distinct brain networks that process different elements of movie scenes—from action and speech to social interactions and complex plot lines. The study found that our brain activity shifts based on the scene’s complexity. Straightforward scenes activate networks for language and object recognition, while more challenging scenes engage executive control networks responsible for problem-solving and comprehension. This innovative approach goes beyond traditional “resting state” brain scans, showing us how our minds respond to dynamic stimuli in real-world conditions.

Elsevier

1y

Saving lives through surgery is no longer exclusive to humans! The study published in Cell Press shows how Florida carpenter ants (Camponotus floridanus) treat their wounded nest-mates by cleaning or amputating infected limbs. Watch the ants in action.